CROSS COUNTRY HEALTHCARE INC (CCRN) Forecast, Price Target & Analyst Ratings
NASDAQ:CCRN • US2274831047
9.62 USD
-0.16 (-1.64%)
At close: Mar 12, 2026
9.62 USD
0 (0%)
After Hours: 3/12/2026, 8:27:28 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CROSS COUNTRY HEALTHCARE INC (CCRN).
Forecast Snapshot
Consensus Price Target
$11.60
+ 20.63% Upside
Next Earnings Forecast
Release DateMay 5, 2026
PeriodQ1 / 2026
EPS Estimate-$0.04
Revenue Estimate242.3M
ChartMill Buy Consensus
70.67%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$11.60
Upside
+ 20.63%
From current price of $9.62 to mean target of $11.60, Based on 15 analyst forecasts
Low
$8.74
Median
$10.71
High
$19.54
Price Target Revisions
1 Month
-0.66%
3 Months
-22.47%
Price Target Summary
15 Wall Street analysts provided a forecast for the next 12 months for CCRN. The average price target is 11.6 USD. This implies a price increase of 20.63% is expected in the next year compared to the current price of 9.62.
The average price target has been revised downward by 22.47% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
70.67%
CCRN was analyzed by 15 analysts. The buy percentage consensus is at 71. So analysts seem to be have mildly positive about CCRN.
In the previous month the buy percentage consensus was at a similar level.
CCRN was analyzed by 15 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-05 | Benchmark | Upgrade | Hold -> Buy |
| 2026-02-03 | Wedbush | Initiate | Neutral |
| 2025-12-09 | UBS | Maintains | Neutral -> Neutral |
| 2025-06-17 | Barrington Research | Maintains | Market Perform -> Market Perform |
| 2025-05-13 | UBS | Maintains | Neutral -> Neutral |
| 2025-03-14 | Barrington Research | Maintains | Market Perform -> Market Perform |
| 2025-02-06 | JMP Securities | Reiterate | Market Perform -> Market Perform |
| 2024-12-10 | Barrington Research | Downgrade | Outperform -> Market Perform |
| 2024-12-05 | Truist Securities | Maintains | Hold -> Hold |
| 2024-11-07 | Benchmark | Maintains | Buy -> Buy |
| 2024-10-21 | Truist Securities | Maintains | Hold -> Hold |
| 2024-08-08 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-08-01 | Truist Securities | Maintains | Hold -> Hold |
| 2024-05-06 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-05-02 | Benchmark | Maintains | Buy -> Buy |
| 2024-02-27 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-02-22 | Benchmark | Maintains | Buy -> Buy |
| 2024-02-22 | Truist Securities | Maintains | Hold -> Hold |
| 2023-12-06 | JMP Securities | Initiate | Market Perform |
| 2023-11-30 | UBS | Initiate | Neutral |
| 2023-11-29 | Barrington Research | Maintains | Outperform -> Outperform |
| 2023-11-03 | Truist Securities | Maintains | Hold -> Hold |
| 2023-11-03 | Jefferies | Downgrade | Buy -> Hold |
| 2023-10-05 | Jefferies | Maintains | Buy -> Buy |
| 2023-08-14 | Barrington Research | Maintains | Outperform -> Outperform |
Next Earnings Forecast Details
Next Earnings Details
Release DateMay 5, 2026
PeriodQ1 / 2026
EPS Estimate-$0.04
Revenue Estimate242.3M
Revenue Q2Q-17.42%
EPS Q2Q-159.50%
Number of Analysts8
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
-1.34%
EPS (1 Month)
-9.99%
EPS (3 Months)
15.38%
Next Earnings Summary
CCRN is expected to report earnings on 5/5/2026. The consensus EPS estimate for the next earnings is -0.04 USD and the consensus revenue estimate is 242.30M USD.
The next earnings revenue estimate has been revised downward by 1.34% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.02B -28.04% | 1.344B -33.46% | 1.054B -21.56% | 1.034B -1.92% | 1.079B 4.35% | |
| EBITDA YoY % growth | 135.516M -53.89% | 19.443M -85.65% | N/A 54.21% | 26.637M -11.16% | 29.409M 10.41% | |
| EBIT YoY % growth | 117.169M -58.35% | 1.243M -98.94% | -3.462M -378.52% | 5.242M 251.42% | 1.32M -74.82% | |
| Operating Margin | 5.80% | 0.09% | -0.33% | 0.51% | 0.12% | |
| EPS YoY % growth | 2.21 -57.98% | 0.45 -79.64% | 0.02 -95.56% | 0.10 388.12% | 0.10 7.09% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.04 -159.50% | 0.03 355.00% | 0.03 -15.00% | 0.03 151.00% | 0.02 157.14% | 0.04 60.00% | 0.04 60.00% | 0.04 33.33% |
| Revenue Q2Q % growth | 242.3M -17.42% | 255.15M -6.90% | 250.89M 0.34% | 258.72M 9.27% | 277.4M 14.49% | 264.96M 3.84% | 257.18M 2.51% | 268.34M 3.72% |
| EBITDA Q2Q % growth | 4.663M -24.02% | 6.462M -39.58% | 6.062M -55.97% | 7.284M 6.98% | 7.477M 60.35% | 6.678M 3.34% | 5.967M -1.57% | 7.613M 4.52% |
| EBIT Q2Q % growth | -33.15K -102.43% | 1.778M -2.47% | 1.523M 88.96% | 2.068M 127.74% | N/A | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
CROSS COUNTRY HEALTHCARE INC / CCRN Forecast FAQ
What is the average price target for CROSS COUNTRY HEALTHCARE INC (CCRN) stock?
15 analysts have analysed CCRN and the average price target is 11.6 USD. This implies a price increase of 20.63% is expected in the next year compared to the current price of 9.62.
What is the next earnings date for CCRN stock?
CROSS COUNTRY HEALTHCARE INC (CCRN) will report earnings on 2026-05-05, after the market close.
Can you provide the consensus estimates for CROSS COUNTRY HEALTHCARE INC next earnings?
The consensus EPS estimate for the next earnings of CROSS COUNTRY HEALTHCARE INC (CCRN) is -0.04 USD and the consensus revenue estimate is 242.30M USD.
What is the consensus rating for CCRN stock?
The consensus rating for CROSS COUNTRY HEALTHCARE INC (CCRN) is 70.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.